Desensitization of epoetin-α in a confirmed case of acute exanthematic pustulosis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 12, 2009, Pages 1797-1798

  Ruano, F J ^a   Garcimartin, M I ^a   Vazquez De La Torre, M ^a   Blanca, M ^a   Canto, G ^a  

^a HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

Author keywords

Chronic kidney disease; Desensitization; Drug allergy; Erythropoietin

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; CORTICOSTEROID; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PREDNISONE; RANITIDINE; RECOMBINANT ERYTHROPOIETIN;

AGED; ARTICLE; CASE REPORT; DESENSITIZATION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EOSINOPHILIA; ERYTHEMA; HUMAN; HYPERTENSION; INTRACUTANEOUS TEST; LYMPHOCYTIC INFILTRATION; MALE; NEUTROPHIL; PAPULAR RASH; PARAKERATOSIS; PREMEDICATION; PRIORITY JOURNAL; PRURITUS; PUSTULE; PUSTULOSIS; SKIN BIOPSY;

AGED, 80 AND OVER; DESENSITIZATION, IMMUNOLOGIC; DRUG ERUPTIONS; EPOETIN ALFA; EXANTHEMA; HUMANS; MALE; TREATMENT OUTCOME;

EID: 70449117441     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02140.x     Document Type: Article

References (4)

1. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987 316 : 73 78.
2. Garcia JE, Sennt C, Pascual C, Fernandez G, Perez-Carral C, Diaz-Tejeiro R et al. Anaphylactic reaction to recombinant human erythropoietin. Nephron 1993 65 : 636 637.
3. Sidoroff A, Dunant A, Viboud C, Halevy S, Bavinck JN, Naldi L et al. Risk factors for acute generalized exanthematous pustulosis (AGEP). Results of a multinational case control study (Euro SCAR). Br J Dermatol 2007 157 : 989 996.
4. Shiohara T, Mizukawa Y. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells. Eur J Dermatol 2007 17 : 201 208.